Literature DB >> 3196660

Cancers of the respiratory tract in mustard gas workers.

D F Easton1, J Peto, R Doll.   

Abstract

In a study of a cohort of 2498 men and 1032 women employed in the manufacture of mustard gas in Cheshire during the second world war 3354 (95%) individuals were successfully traced for mortality to the end of 1984. Large and highly significant excesses were observed as compared with national death rates for deaths from cancer of the larynx (11 deaths observed, 4.04 expected, p = 0.003), pharynx (15 observed, 2.73 expected, p less than 0.001), and all other buccal cavity and upper respiratory sites combined (lip, tongue, salivary gland, mouth, nose) (12 observed, 4.29 expected, p = 0.002). For lung cancer, a highly significant but more moderate excess was observed (200 observed, 138.39 expected, p less than 0.001). Significant excesses were also observed for deaths from acute and chronic non-malignant respiratory disease (131 observed, 91.87 expected and 185 observed, 116.31 expected, respectively). The risks for cancers of the pharynx and lung were significantly related to duration of employment. None of these results is substantially altered when expected numbers are calculated from Cheshire urban areas rather than national rates, although the relative risks for lung cancer and non-malignant respiratory disease are substantially reduced if rates for Merseyside, the nearest large conurbation, are used. The results provide strong evidence that exposure to mustard gas can cause cancers of the upper respiratory tract and some evidence that it can cause lung cancer and non-malignant respiratory disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196660      PMCID: PMC1009673          DOI: 10.1136/oem.45.10.652

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  7 in total

1.  Lung cancer in World War I veterans: possible relation to mustard-gas injury and 1918 influenza epidemic.

Authors:  G W BEEBE
Journal:  J Natl Cancer Inst       Date:  1960-12       Impact factor: 13.506

2.  Mustard gas poisoning, chronic bronchitis, and lung cancer; an investigation into the possibility that poisoning by mustard gas in the 1914-18 war might be a factor in the production of neoplasia.

Authors:  R A CASE; A J LEA
Journal:  Br J Prev Soc Med       Date:  1955-04

3.  Spiramycin the the prevention of postoperative staphylococcal infection.

Authors:  J A Macfarlane; A A Mitchell; J M Walsh; J J Robertson
Journal:  Lancet       Date:  1968-01-06       Impact factor: 79.321

4.  Elementary methods of cohort analysis.

Authors:  N E Breslow
Journal:  Int J Epidemiol       Date:  1984-03       Impact factor: 7.196

5.  Lung cancer mortality in World War I veterans with mustard-gas injury: 1919-1965.

Authors:  J E Norman
Journal:  J Natl Cancer Inst       Date:  1975-02       Impact factor: 13.506

6.  The analysis of mortality by the subject-years method.

Authors:  G Berry
Journal:  Biometrics       Date:  1983-03       Impact factor: 2.571

7.  Cancer of the larynx and other occupational hazards of mustard gas workers.

Authors:  K P Manning; D C Skegg; P M Stell; R Doll
Journal:  Clin Otolaryngol Allied Sci       Date:  1981-06
  7 in total
  17 in total

1.  2,6-Dithiopurine, a nucleophilic scavenger, protects against mutagenesis in mouse skin treated in vivo with 2-(chloroethyl) ethyl sulfide, a mustard gas analog.

Authors:  Stephen Boulware; Tammy Fields; Elizabeth McIvor; K Leslie Powell; Erika L Abel; Karen M Vasquez; Michael C MacLeod
Journal:  Toxicol Appl Pharmacol       Date:  2012-06-23       Impact factor: 4.219

2.  Myocardial perfusion abnormalities in chemical warfare patients intoxicated with mustard gas.

Authors:  Ali Gholamrezanezhad; Mohsen Saghari; Arsalan Vakili; Sahar Mirpour; Mohammad Hossein Farahani
Journal:  Int J Cardiovasc Imaging       Date:  2006-09-14       Impact factor: 2.357

3.  A recent exposure to mustard gas in the United States: clinical findings of a cohort (n = 247) 6 years after exposure.

Authors:  Yuruk Iyriboz
Journal:  MedGenMed       Date:  2004-10-22

Review 4.  Sulfur mustard inhalation: mechanisms of injury, alteration of coagulation, and fibrinolytic therapy.

Authors:  Carl W White; Raymond C Rancourt; Livia A Veress
Journal:  Ann N Y Acad Sci       Date:  2016-07-06       Impact factor: 5.691

Review 5.  Inhalational Constrictive Bronchiolitis: The Evolution of our Understanding of this Disease.

Authors:  Daniel E Banks; Michael J Morris
Journal:  Lung       Date:  2021-08-20       Impact factor: 2.584

6.  2,6-Dithiopurine blocks toxicity and mutagenesis in human skin cells exposed to sulfur mustard analogues, 2-chloroethyl ethyl sulfide and 2-chloroethyl methyl sulfide.

Authors:  K Leslie Powell; Stephen Boulware; Howard Thames; Karen M Vasquez; Michael C MacLeod
Journal:  Chem Res Toxicol       Date:  2010-03-15       Impact factor: 3.739

Review 7.  Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.

Authors:  Michael P Shakarjian; Diane E Heck; Joshua P Gray; Patrick J Sinko; Marion K Gordon; Robert P Casillas; Ned D Heindel; Donald R Gerecke; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2009-10-15       Impact factor: 4.849

8.  Sulforaphane induces phase II detoxication enzymes in mouse skin and prevents mutagenesis induced by a mustard gas analog.

Authors:  E L Abel; S Boulware; T Fields; E McIvor; K L Powell; J DiGiovanni; K M Vasquez; M C MacLeod
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-30       Impact factor: 4.219

9.  Mustard gas exposure and carcinogenesis of lung.

Authors:  Alireza Hosseini-khalili; David D Haines; Ehsan Modirian; Mohammadreza Soroush; Shahriar Khateri; Rashmi Joshi; Kazem Zendehdel; Mostafa Ghanei; Charles Giardina
Journal:  Mutat Res       Date:  2009-06-24       Impact factor: 2.433

10.  Teratogenic effects of sulfur mustard on mice fetuses.

Authors:  Nasrin Sanjarmoosavi; Naser Sanjarmoosavi; Marziyeh Shahsavan; Mohammad Hassanzadeh-Nazarabadi
Journal:  Iran J Basic Med Sci       Date:  2012-05       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.